Medicare Payment Advisory Commission

Isothermal Nucleic Acid Amplification Technology Market worth $8.83 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

Retrieved on: 
Friday, November 24, 2023
Preventive healthcare, ID, Conditional sentence, Prevalence, CMV, Viral load, US Foods, Coronavirus, Patient, Gynaecology, CE marking, NAT, FDA, Genetic testing, COVID-19, Emergency Use Authorization, CMS, Food and Drug Administration, Cancer, Cytomegalovirus, Medicare, Medicare Payment Advisory Commission, Obstetrics, Malaria, History of Stanford Medicine, Vaccine, Pharmaceutical industry, Grifols

Grifols (Spain), for example, received the CE Mark in June 2022 for the Procleix Plasmodium Assay, a nucleic acid test (NAT) specifically approved for screening blood donors for malaria.

Key Points: 
  • Grifols (Spain), for example, received the CE Mark in June 2022 for the Procleix Plasmodium Assay, a nucleic acid test (NAT) specifically approved for screening blood donors for malaria.
  • Hologic, Inc. (US) got US Food and Drug Administration (FDA) approval for the Aptima CMV Quant Assay in May 2022.
  • The viral load of cytomegalovirus (CMV) will be quantified in patients who have received an organ or stem cell transplant.
  • Since of the region's high prevalence of chronic diseases, technological advancement in isothermal nucleic acid amplification technology (INAAT), and increasing adoption of INAAT over conventional techniques, North America dominates the Isothermal Nucleic Acid Amplification Technology (INAAT) market.

Isothermal Nucleic Acid Amplification Technology Market worth $8.83 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

Retrieved on: 
Friday, November 24, 2023
Preventive healthcare, ID, Conditional sentence, Prevalence, CMV, Viral load, US Foods, Coronavirus, Patient, Gynaecology, CE marking, NAT, FDA, Genetic testing, COVID-19, Emergency Use Authorization, CMS, Food and Drug Administration, Cancer, Cytomegalovirus, Medicare, Medicare Payment Advisory Commission, Obstetrics, Malaria, History of Stanford Medicine, Vaccine, Pharmaceutical industry, Grifols

Grifols (Spain), for example, received the CE Mark in June 2022 for the Procleix Plasmodium Assay, a nucleic acid test (NAT) specifically approved for screening blood donors for malaria.

Key Points: 
  • Grifols (Spain), for example, received the CE Mark in June 2022 for the Procleix Plasmodium Assay, a nucleic acid test (NAT) specifically approved for screening blood donors for malaria.
  • Hologic, Inc. (US) got US Food and Drug Administration (FDA) approval for the Aptima CMV Quant Assay in May 2022.
  • The viral load of cytomegalovirus (CMV) will be quantified in patients who have received an organ or stem cell transplant.
  • Since of the region's high prevalence of chronic diseases, technological advancement in isothermal nucleic acid amplification technology (INAAT), and increasing adoption of INAAT over conventional techniques, North America dominates the Isothermal Nucleic Acid Amplification Technology (INAAT) market.

APCI to Feds: Stop Further Healthcare Vertical Integration in Optum-Amedisys Deal

Retrieved on: 
Thursday, October 19, 2023
Amedisys, Federal Trade Commission, PBM, Medicare Payment Advisory Commission, APCI, Section 5 of the Indian Limitation Act, Medicare, Congress, Texas Juvenile Justice Department, Federation, United States Congress, UnitedHealth Group, Federal Trade Commission Act of 1914, Acquisition, Optum, Justice minister, Justice, U.S. Department of Justice Office of Legislative Affairs, Health, Medicare Part D, Pharmacy, Office of Inspector General, U.S. Department of Health and Human Services, FTC, Pharmacist, Patient, Letter, DOJ, Dietary supplement, Health insurance

The acquisition represents a further descent into an already vertically integrated healthcare supply chain.

Key Points: 
  • The acquisition represents a further descent into an already vertically integrated healthcare supply chain.
  • "APCI has been one of the loudest and most consistent voices in opposing further vertical and horizontal integration by large insurers and their affiliated PBMs," said APCI CEO Tim Hamrick.
  • "Community pharmacists have seen first-hand what vertical integration has done in pharmacy and the burden it has caused patients.
  • APCI is committed to advocating on behalf of patients and the community pharmacies that serve them against further large insurer/PBM integration before agencies, U.S. Congress, and in the states."

Study: PBMs setting wildly variable prescription prices for patients at the counter, per APCI

Retrieved on: 
Tuesday, September 19, 2023
Attention, Drug, General counsel, APCI, Health care, Pharmacy, National Average Drug Acquisition Cost, PBM, Congress, GAO, Acquisition, Patient, FTC, Map, Data, Medicare Payment Advisory Commission, NADAC, Pharmaceutical industry

Additionally, the study reveals wild swings in prescription pricing set by PBMs and charged to patients.

Key Points: 
  • Additionally, the study reveals wild swings in prescription pricing set by PBMs and charged to patients.
  • The study was performed by data analytics firm 3 Axis Advisors and was sponsored by American Pharmacy Cooperative, Inc. (APCI).
  • The study is replete with examples of variability and the arbitrariness of PBM-set drug prices.
  • Simply put, the system is broken, and PBMs can no longer be trusted to set drug prices."

Bipartisan House Lawmakers Introduce Preserving Access to Home Health Act to Protect Patients from Harmful Home Health Program Cuts

Retrieved on: 
Wednesday, August 2, 2023
American Hospital Association, Medicare Advantage, CMS, Legislation, Partnership, Member of Congress, Centers for Medicare & Medicaid Services, Hospital, Incumbency advantage for appointed U.S. senators, NAHC, Commission, Sewell, Policy, Patient, Smith, Representative Smith, Hardship, AHA, Bipartisan Budget Act of 2018, Medicare, Congress, Representative, Risk, HH, National Association for Home Care & Hospice, National Association, Medicare Payment Advisory Commission, Louisiana House of Representatives, House, Behavior, Health insurance, Medicaid, Hospice

WASHINGTON, Aug. 2, 2023 /PRNewswire/ -- The Partnership for Quality Home Healthcare (PQHH) and the National Association for Home Care & Hospice (NAHC) today commended Representatives Terri Sewell (AL-7) and Adrian Smith (NE-3) for introducing the Preserving Access to Home Health Act of 2023 in the U.S. House of Representatives. If enacted, the bill would safeguard access to essential, home-based, clinically advanced healthcare services by preventing the Centers for Medicare & Medicaid Services (CMS) from implementing cuts as high as $20 billion over the next decade.

Key Points: 
  • "The home health community calls on Congress to ensure the stability that patients and providers urgently need.
  • Since Medicare has again proposed deep cuts to home health in 2024, Congress must act to protect the care their constituents prefer and want."
  • "Data suggest that Medicare's continued cuts to home health are restricting patient access to the safest and lowest-cost care setting following a hospital stay."
  • Senators Debbie Stabenow (D-MI) and Susan Collins (R-ME) introduced the Preserving Access to Home Health Act ( S.2137 ) in the U.S. Senate on June 22.

Henry Schein Medical and Medpod Inc. Join Forces to Launch Medpac

Retrieved on: 
Monday, July 31, 2023
General Health, Medical Devices, Health, Health Technology, Telemedicine, Virtual Medicine, Wi-Fi, Henry Schein, United States National Library of Medicine, Rising Medical Solutions, House, School, National library, Patient, Emergency medical services, Telehealth, Nursing, Medicare Payment Advisory Commission

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), and Medpod Inc. today announced the launch of Medpac – a lightweight, portable telediagnostic solution that allows health care providers to offer comprehensive professional care regardless of location, helping to bridge the gap between remote telemedicine consultations and in-person office visits.

Key Points: 
  • Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), and Medpod Inc. today announced the launch of Medpac – a lightweight, portable telediagnostic solution that allows health care providers to offer comprehensive professional care regardless of location, helping to bridge the gap between remote telemedicine consultations and in-person office visits.
  • View the full release here: https://www.businesswire.com/news/home/20230714052658/en/
    A compact, backpack version of Medpod Inc.’s MobileDoc , Medpac houses a set of telediagnostic devices, enabling health care providers to conduct examinations remotely.
  • Exclusively distributed by Henry Schein Medical, Medpac is suitable for a range of applications, including ambulatory surgery centers, emergency medical services, expansion of off-site point of care, health professional storage areas, house calls, military, schools, and worksites.
  • “We are excited to join forces with Medpod Inc. to introduce Medpac, which will further our efforts to help health care providers deliver exceptional care to patients in any setting,” said Todd Stack, General Manager of Medical Solutions at Henry Schein.

Home Health Leaders Applaud Bipartisan Introduction of Preserving Access to Home Health Act of 2023

Retrieved on: 
Thursday, June 22, 2023
Medicare Advantage, CMS, Legislation, Partnership, Centers for Medicare & Medicaid Services, NAHC, Commission, Policy, Bipartisan Budget Act of 2018, Medicare, Congress, Congressional Budget Office, Patient, CBO, National Association for Home Care & Hospice, Partnership for America's Health Care Future, National Association, Medicare Payment Advisory Commission, Behavior, Hospital, Health insurance, Pharmaceutical industry, Medicaid, Hospice

This change would take effect and be implemented as if it was included in the Bipartisan Budget Act of 2018 that included home health provisions leading to PDGM implementation.

Key Points: 
  • This change would take effect and be implemented as if it was included in the Bipartisan Budget Act of 2018 that included home health provisions leading to PDGM implementation.
  • According to the Partnership and NAHC, the Preserving Access to Home Health Act of 2023 is immediately needed to protect the future viability of the Medicare home health program, which more than 3 million older Americans rely on annually.
  • When considering the legislation, home health leaders urge lawmakers to consider:
    The Congressional Budget Office (CBO) projects Medicare home health spending to drop at an alarming rate.
  • This legislation offers the stability the Medicare home health community so urgently needs," said Joanne Cunningham, CEO of the Partnership.

Surround Care Names Dr. Craig E. Samitt to be Chief Executive Officer of its National Physician Enterprise

Retrieved on: 
Tuesday, February 28, 2023
General Health, Hospitals, Health, Practice Management, Managed Care, Harvard Pilgrim Health Care, Blue Cross, MD, Texas Health Resources, MBA, Physician, Partnership, Blue Shield, Culture, Esse, Atrius Health, Modern Healthcare, Multimedia, Medicare Payment Advisory Commission, Management, Anthem, Navvy

Surround Care, a leading healthcare transformation company, today announced Craig E. Samitt, MD, MBA, has joined the company leading its National Physician Enterprise.

Key Points: 
  • Surround Care, a leading healthcare transformation company, today announced Craig E. Samitt, MD, MBA, has joined the company leading its National Physician Enterprise.
  • Dr. Samitt will serve as the chief executive officer of the National Physician Enterprise business unit and executive vice president at Navvis, a Surround Care company.
  • Building off of the recent announcement of Esse Health becoming a Surround Care company, Dr. Samitt will lead the company’s national footprint expansion of physician enterprises, through partnerships, joint ventures, and acquisitions, allowing physician groups to thrive on their journey to delivering transformative care.
  • View the full release here: https://www.businesswire.com/news/home/20230228005115/en/
    Dr. Craig Samitt, CEO, National Physician Enterprise, Surround Care and Executive Vice President, Navvis (Photo: Business Wire)
    Dr. Samitt has nearly 30 years of experience in healthcare leadership and transformation, most recently serving as president and chief executive officer of Blue Cross and Blue Shield of Minnesota (BCBSMN).

CMS Temporarily Suspends Medicare Payments to Modern Vascular

Retrieved on: 
Thursday, February 23, 2023
Medicare Payment Advisory Commission, CMS, DOJ, Health insurance, Hospital

Aventura, Feb. 23, 2023 (GLOBE NEWSWIRE) -- On February 9, 2023, Modern Vascular facilities received letters from the CMS program wherein the facilities were advised that Medicare Payments to Modern Vascular are suspended pending the outcome of the current DOJ lawsuit.

Key Points: 
  • Aventura, Feb. 23, 2023 (GLOBE NEWSWIRE) -- On February 9, 2023, Modern Vascular facilities received letters from the CMS program wherein the facilities were advised that Medicare Payments to Modern Vascular are suspended pending the outcome of the current DOJ lawsuit.
  • The Modern Vascular legal team is actively engaged with the appropriate CMS authorities and is working towards an expedient resolution to this matter.
  • To be clear, Modern Vascular has not been sanctioned or terminated by the Medicare Program, rather payments to the facilities have been temporarily placed on hold.
  • While this is a temporary setback, Modern Vascular continues on its mission of preserving the limbs of an otherwise underserved and largely ignored patient population.

Pat Wang, President & CEO of Healthfirst, Named to Modern Healthcare’s Top Diversity Leaders List

Retrieved on: 
Tuesday, October 18, 2022
General Health, Health, Professional Services, Insurance, Managed Care, Congress, Medicare Payment Advisory Commission, Disease, MH, Policy, Organization, AHIP, Health equity, Multimedia, Modern Healthcare, Medicare, Industry, Health, Federal Reserve Bank, COVID-19, Public health, Hospital, Orange, Health care

Modern Healthcare (MH) has recognized Healthfirst President and CEO Pat Wang as one of 2022s Top Diversity Leaders.

Key Points: 
  • Modern Healthcare (MH) has recognized Healthfirst President and CEO Pat Wang as one of 2022s Top Diversity Leaders.
  • (Healthfirst serves members in New York City and on Long Island, as well as in Westchester, Rockland, Sullivan, and Orange counties.)
  • The honorees on Modern Healthcares 2022 lists of Top Diversity Leaders and Organizations demonstrate a willingness to devote the resources necessary to execute meaningful diversity, equity, and inclusion initiatives, said Mary Ellen Podmolik, Modern Healthcares editor.
  • For information or questions about the Top Diversity Leaders recognition program or awards gala, please contact: